Immunofluorescence Assay Market Research Report – Forecast to 2027

Global Immunofluorescence Assay Market Research Report, by Technique (Primary, Secondary), by Product Type (Antibodies, Kits), by Application (Clinical research), End-User (Clinical Diagnostics, Hospitals & Research Institutes) - Global Forecast Till 2027

ID: MRFR/LS/4718-HCR | February 2021 | Region: Global | 100 pages

Please note that the assessment period of report has been updated from 2018-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario


The global Immunofluorescence Assay market is expected to reach an approximate CAGR of 5.8% during the forecast period. The increase in biological studies in research and development for detection of biomolecules like proteins, glycans, and small biological and non-biological molecules of various diseases drives the market growth. Immunofluorescence Assays are used for rapid and sensitive diagnostics of various chronic diseases like cancer, autoimmune diseases, infectious diseases like HIV, neurological diseases such as Alzheimer's and Parkinson's disease and chronic diseases like cancer. Immunofluorescence assay is a primary detection test used for patients suspected with autoimmune disease. According to National Institutes of Health (2012), autoimmune diseases are most prevalent among other diseases, and 23.5 million people in America suffer from autoimmune diseases, whereas 9 million people have cancer. Furthermore, according to Alzheimer's Association in 2018, 5.7 million Americans are affected by Alzheimer’s disease.  Thus, such high incidence of autoimmune and neurological diseases and increasing government funding enhances the growth in this market. Also, growing demand for rapid and precise measurement of biomolecules, increased use of Immunofluorescence Assay for diagnostic and research purposes, increased R&D activities and advanced technology are the key factors for the market to grow.


However, factors such as expensive diagnostic kits, chances of cross contaminations, shortage of skilled labor and weak detection signals are expected to restrict the market growth during the forecast period.


Research Methodology


Market Research Future research is conducted by industry experts who offer insights into industry structure, market segmentation, assessment, Competitive Landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments and categories geographically presented are studied and are estimated based on the primary and secondary research.



  • Primary Research


Extensive primary research was conducted to gain a deeper insight into the market and the industry performance. In this particular report, we have conducted primary surveys (interviews) with key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of the major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.



  • Secondary Research


Secondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and commercial study of the global Immunofluorescence Assay market. It was also used to obtain key information about major players, market classification, and segmentation according to industry trends, geographical markets, and developments related to the market and perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company websites, international organization of chemical manufacturers, some paid databases, and many others.


Segmentation


The global immunofluorescence assay market is segmented on the basis of technique, product type, application and end user. The immunofluorescence assay market, by technique, is sub-segmented into primary (direct) immunofluorescence assays, secondary (indirect) immunofluorescence assays, and microimmunofluorescence. Secondary (indirect) immunofluorescence assays category includes salt split technique, antigenic mapping method, and double staining method.


On the basis of product type, the market is categorized into antibodies, kits and reagents, instruments, labeling dyes and species type. Instruments are further sub-segmented into microscopes and imaging analysis systems. The application segment includes clinical research, clinical diagnostics, research & development. Clinical diagnostics segment is categorized into infectious diseases, cancer, cardiovascular diseases, autoimmune diseases, neurological diseases. On the basis of end-user, the market is segmented into biotechnology companies, hospitals & research institutes, contract research organizations and diagnostic centers.


On the basis of region, the global Immunofluorescence Assay market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.


The Americas is sub-segmented into North America and South America. The North American region is further segmented into the U.S. and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the U.K., Spain, and the rest of Western Europe. The Asia Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.


Key players


Some of the key players for the global Immunofluorescence Assay market are Abcam plc, Thermo Fisher Scientific, BioLegend, Inc., Enzo Life Sciences, Inc., Sino Biological Inc. BioTek Instruments, Inc., Bio-Rad Laboratories, Inc., Zyagen, Cell Signaling Technology, Inc., PerkinElmer Inc., Becton Dickinson and Company, Merck, Agilent Technologies, TCS Biosciences Ltd, Maxvision Biosciences Inc. and Others.


Regional Market Summary


Global Immunofluorescence Assay Market Share (%), by Region, 2017


 Immunofluorescence Assay Market Share


Sources: National Institutes of Health, U.S. Investments in Medical and Health Research and Development, Department of Biotechnology, Department of Science and Technology


The Immunofluorescence Assay market is dominated by North America owing to the high prevalence of chronic diseases and high R&D investments within this region stimulate market growth. According to the U.S. Investments in Medical and Health Research and Development in 2016, the United States invested total $171.8 billion in medical and health R&D and the investment increased by 20.6% from 2013 to 2016. Also, the rising adoption of technologically advanced systems for early diagnosis of diseases drives the market growth in this region.


It is estimated that Europe stood second in the global Immunofluorescence Assay market. Rising prevalence of chronic diseases such as cancer is driving the growth of this market in Europe. According to the Eurostat in 2014, 272 thousand people deaths were due to lung cancer. Thus, increasing prevalence of cancer in Europe drives the market growth. Furthermore, rapidly growing biotechnology sector in Europe is expected to boost the market in this region.


Asia Pacific was projected to be the fastest growing region for the global Immunofluorescence Assay market. Key factors such as growing patient pool, high incidence of chronic diseases, developing healthcare infrastructure and increasing research & development activities in biotechnology sector influences the market in this region. Also, the presence of major market players China, India, and Japan drive the market growth.


The Middle East and Africa holds the least share in the global Immunofluorescence Assay market due to the presence of stringent government policies and poor economies. However, growing awareness among the population and high investments by private market players in this region can boost the market growth. 


Market Segmentation and Key Market Players


Global Immunofluorescence Assays Market, by Technique,



  • Primary (Direct) Immunofluorescence assays

  • Secondary (Indirect) Immunofluorescence assays

    • Salt split technique

    • Antigenic mapping method

    • Double Staining method



  • Micro Immunofluorescence


Global Immunofluorescence Assays Market, by Product Type



  • Antibodies

  • Kits and reagents

  • Instruments

  • Microscopes

  • Imaging Analysis Systems

  • Labeling dyes

  • Species Product Type


Global Immunofluorescence Assays Market, by Application



  • Clinical research

  • Clinical Diagnostics

  • Infectious Diseases

  • Cancer

  • Cardiovascular Diseases

  • Autoimmune Diseases

  • Neurological Diseases

  • Research & Development


Global Immunofluorescence Assays Market, by End-User



  • Biotechnology Companies

  • Hospitals & Research Institutes

  • Contract Research Organizations

  • Diagnostic centers


Global Immunofluorescence Assay Market, by Region



  • The Americas

  • Europe

  • Asia Pacific

  • The Middle East & Africa


Global Immunofluorescence Assay Market, by Key Players



  • Abcam plc

  • Thermo Fisher Scientific

  • BioLegend, Inc.

  • Enzo Life Sciences, Inc.

  • Sino Biological Inc.

  • BioTek Instruments, Inc.

  • Bio-Rad Laboratories, Inc.

  • Zyagen

  • Cell Signaling Technology, Inc.

  • PerkinElmer Inc.

  • Becton Dickinson and Company

  • Merck

  • Agilent Technologies,

  • TCS Biosciences Ltd,

  • Maxvision Biosciences Inc.


Intended Audience

  • Pharmaceutical companies

  • Biotechnological institutes

  • Government and private laboratories

  • Research and Development (R&D) companies

  • Medical research laboratories

  • Market research and consulting service providers



Frequently Asked Questions (FAQ) :


The global immunofluorescence assay market can grow with 5.8% CAGR during the forecast period of 2018 to 2023.

Growing demand for autoimmune disease detection can inspire growth for the immunofluorescence assay market.

Factors like chances of cross contaminations, expensive diagnostic kits, lack of skilled labor, and weak detection signals can prevent the immunofluorescence assay market from growth.

The immunofluorescence assay market applications mostly take place in segments like clinical diagnostics, clinical research, research & development.

The North American immunofluorescence assay market would have the edge in the global competition.

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Immunofluorescence Assays Market, by Technique

6.1 Introduction

6.2 Primary (Direct) Immunofluorescence assays

6.2 Secondary (Indirect) Immunofluorescence assays

6.2.1 Salt split technique

6.2.2 Antigenic mapping method

6.2.3 Double Staining method

6.2 Micro Immunofluorescence

Chapter 7. Global Immunofluorescence Assays Market, by Product Type

7.1 Introduction

7.2 Antibodies

7.3 Kits and reagents

7.4 Instruments

7.4.1 Microscopes

7.4.2 Imaging Analysis Systems

7.5 Labeling dyes

7.6 Species Product Type

Chapter 8. Global Immunofluorescence Assays Market, by Application

8.1 Introduction

8.2 Clinical research

8.3 Clinical Diagnostics

8.3.1 Infectious Diseases

8.3.2 Cancer

8.3.3 Cardiovascular Diseases

8.3.4 Autoimmune Diseases

8.3.5 Neurological Diseases

8.3 Research & Development

Chapter 9. Global Immunofluorescence Assays Market, by End-User

9.1 Introduction

9.2 Biotechnology Companies

9.3 Hospitals & Research Institutes

9.4 Contract Research Organizations

9.4 Diagnostic centers

Chapter 10. Global Immunofluorescence Assays Market, by Region

10.1 Introduction

10.2 America

10.2.1 North America

10.2.1.1 U.S.

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 U.K.

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic of Korea

10.4.6 Rest of Asia Pacific

10.5 The Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of the Middle East & Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

Chapter 12 Company Profiles

12.1 Abcam PLC

12.1.1 Company Overview

12.1.2 Product Type Overview

12.1.3 Financials

12.2.4 Key Developments

12.1.5 SWOT Analysis

12.2 Thermo Fisher Scientific

12.2.1 Company Overview

12.2.2 Product Type Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 BioLegend, Inc

12.3.1 Company Overview

12.3.2 Product Type Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Bio-Rad Laboratories

12.4.1 Company Overview

12.4.2 Product Type/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Enzo Life Sciences

12.5.1 Company Overview

12.5.2 Product Type Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 Sino Biological Inc

12.6.1 Company Overview

12.6.2 Product Type Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 BIOTEK INSTRUMENTS, INC

12.7.1 Overview

12.7.2 Product Type Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Zyagen

12.8.1 Overview

12.8.2 Product Type Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Cell Signaling Technology, Inc

12.9.1 Overview

12.9.2 Product Type Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 PerkinElmer Inc

12.10.1 Overview

12.10.2 Product Type Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.11 Becton Dickinson and Company

12.11.1 Overview

12.11.2 Product Type Overview

12.11.3 Financials

12.11.4 Key Developments

12.11.5 SWOT Analysis

12.12 Merck

12.12.1 Overview

12.12.2 Product Type Overview

12.12.3 Financials

12.12.4 Key Developments

12.12.5 SWOT Analysis

12.13 Agilent Technologies

12.13.1 Overview

12.13.2 Product Type Overview

12.13.3 Financials

12.13.4 Key Developments

12.13.5 SWOT Analysis

12.14 TCS Biosciences Ltd

12.14.1 Overview

12.14.2 Product Type Overview

12.14.3 Financials

12.14.4 Key Developments

12.14.5 SWOT Analysis

12.15 Maxvision Biosciences Inc

12.15.1 Overview

12.15.2 Product Type Overview

12.15.3 Financials

12.15.4 Key Developments

12.15.5 SWOT Analysis

12.16 Others

Chapter 14 Appendix

LIST OF TABLES

Table 1 Immunofluorescence Assays Market Industry Synopsis, 2020-2027

Table 2 Global Immunofluorescence Assays Market Estimates & Forecast, 2020-2027, (USD Million)

Table 3 Global Immunofluorescence Assays Market, by Region, 2020-2027, (USD Million)

Table 4 Global Immunofluorescence Assays Market, by Technique, 2020-2027, (USD Million)

Table 5 Global Immunofluorescence Assays Market, by Product Type, 2020-2027, (USD Million)

Table 7 Global Immunofluorescence Assays Market, by Application, 2020-2027, (USD Million)

Table 8 Global Immunofluorescence Assays Market, by End-User, 2020-2027, (USD Million

Table 9 North America Immunofluorescence Assays Market, by Technique, 2020-2027, (USD Million)

Table 10 North America Immunofluorescence Assays Market, by Product Type, 2020-2027, (USD Million)

Table 12 North America Immunofluorescence Assays Market, by Application, 2020-2027, (USD Million)

Table 13 North America Immunofluorescence Assays Market, by End-User, 2020-2027, (USD Million)

Table 14 U.S. Immunofluorescence Assays Market, by Technique, 2020-2027, (USD Million)

Table 15 U.S. Immunofluorescence Assays Market, by Product Type, 2020-2027, (USD Million)

Table 17 U.S. Immunofluorescence Assays Market, by Application, 2020-2027, (USD Million)

Table 18 U.S. Immunofluorescence Assays Market, by End-User, 2020-2027, (USD Million)

Table 19 Canada Immunofluorescence Assays Market, by Technique, 2020-2027, (USD Million)

Table 20 Canada Immunofluorescence Assays Market, by Product Type, 2020-2027, (USD Million)

Table 22 Canada Immunofluorescence Assays Market, by Application, 2020-2027, (USD Million)

Table 23 Canada Immunofluorescence Assays Market, by End-User, 2020-2027, (USD Million)

Table 24 South America Immunofluorescence Assays Market, by Technique, 2020-2027, (USD Million)

Table 25 South America Immunofluorescence Assays Market, by Product Type, 2020-2027, (USD Million)

Table 27 South America Immunofluorescence Assays Market, by Application, 2020-2027, (USD Million)

Table 28 South America Immunofluorescence Assays Market, by End-User, 2020-2027, (USD Million)

Table 29 Europe Immunofluorescence Assays Market, Technique, 2020-2027, (USD Million)

Table 30 Europe Immunofluorescence Assays Market, Product Type, 2020-2027, (USD Million)

Table 32 Europe Immunofluorescence Assays Market, by Application, 2020-2027, (USD Million)

Table 33 Europe Immunofluorescence Assays Market, by End-User, 2020-2027, (USD Million)

Table 34 Western Europe Immunofluorescence Assays Market, by Technique, 2020-2027, (USD Million)

Table 35 Western Europe Immunofluorescence Assays Market, by Product Type, 2020-2027, (USD Million)

Table 37 Western Europe Immunofluorescence Assays Market, by Application, 2020-2027, (USD Million)

Table 38 Western Europe Immunofluorescence Assays Market, by End-User, 2020-2027, (USD Million)

Table 39 Eastern Europe Immunofluorescence Assays Market, by Technique, 2020-2027, (USD Million)

Table 40 Eastern Europe Immunofluorescence Assays Market, by Product Type, 2020-2027, (USD Million)

Table 42 Eastern Europe Immunofluorescence Assays Market, by Application, 2020-2027, (USD Million)

Table 43 Eastern Europe Immunofluorescence Assays Market, by End-User, 2020-2027, (USD Million)

Table 44 Asia Pacific Immunofluorescence Assays Market, by Technique, 2020-2027, (USD Million)

Table 45 Asia Pacific Immunofluorescence Assays Market, by Product Type, 2020-2027, (USD Million)

Table 47 Asia Pacific Immunofluorescence Assays Market, by Application, 2020-2027, (USD Million)

Table 48 Asia Pacific Immunofluorescence Assays Market, by End-User, 2020-2027, (USD Million)

Table 49 The Middle East & Africa Immunofluorescence Assays Market, by Technique, 2020-2027, (USD Million)

Table 50 The Middle East & Africa Immunofluorescence Assays Market, by Product Type, 2020-2027, (USD Million)

Table 52 The Middle East & Africa Immunofluorescence Assays Market, by Application, 2020-2027, (USD Million)

Table 53 The Middle East & Africa Immunofluorescence Assays Market, by End-User, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Immunofluorescence Assays Market

Figure 3 Market Dynamics for Global Immunofluorescence Assays Market

Figure 4 Global Immunofluorescence Assays Market Share, by Technique 2020

Figure 4 Global Immunofluorescence Assays Market Share, by Product Type 2020

Figure 5 Global Immunofluorescence Assays Market Share, by Application 2020

Figure 6 Global Immunofluorescence Assays Market Share, by End-User, 2020

Figure 7 Global Immunofluorescence Assays Market Share, by Region, 2020

Figure 8 North America Immunofluorescence Assays Market Share, by Country, 2020

Figure 9 Europe Immunofluorescence Assays Market Share, by Country, 2020

Figure 10 Asia Pacific Immunofluorescence Assays Market Share, by Country, 2020

Figure 11 Middle East & Africa Immunofluorescence Assays Market Share, by Country, 2020

Figure 12 Global Immunofluorescence Assays Market: Company Share Analysis, 2020 (%)

Figure 13 Abcam PLC: Key Financials

Figure 14 Abcam PLC: Segmental Revenue

Figure 15 Abcam PLC: Geographical Revenue

Figure 16 Thermo Fisher Scientific: Key Financials

Figure 17 Thermo Fisher Scientific: Segmental Revenue

Figure 18 Thermo Fisher Scientific: Geographical Revenue

Figure 19 BioLegend, Inc: Key Financials

Figure 20 BioLegend, Inc: Segmental Revenue

Figure 21 BioLegend, Inc: Geographical Revenue

Figure 22 Bio-Rad Laboratories: Key Financials

Figure 23 Bio-Rad Laboratories: Segmental Revenue

Figure 24 Bio-Rad Laboratories: Geographical Revenue

Figure 25 Sino Biological Inc: Key Financials

Figure 26 Sino Biological Inc: Segmental Revenue

Figure 27 Sino Biological Inc: Geographical Revenue

Figure 28 Enzo Life Sciences: Key Financials

Figure 29 Enzo Life Sciences: Segmental Revenue

Figure 30 Enzo Life Sciences: Geographical Revenue

Figure 31 BIOTEK INSTRUMENTS, INC: Key Financials

Figure 32 BIOTEK INSTRUMENTS, INC: Segmental Revenue

Figure 33 BIOTEK INSTRUMENTS, INC: Geographical Revenue

Figure 34 Zyagen: Key Financials

Figure 35 Zyagen: Segmental Revenue

Figure 36 Zyagen: Geographical Revenue

Figure 37 Cell Signaling Technology, Inc: Key Financials

Figure 38 Cell Signaling Technology, Inc: Segmental Revenue

Figure 39 Cell Signaling Technology, Inc: Geographical Revenue

Figure 40 PerkinElmer Inc: Key Financials

Figure 41 PerkinElmer Inc: Segmental Revenue

Figure 42 PerkinElmer Inc: Geographical Revenue

Figure 43 Maxvision Biosciences Inc: Key Financials

Figure 44 Maxvision Biosciences Inc: Segmental Revenue

Figure 45 Maxvision Biosciences Inc: Geographical Revenue

Figure 46 Becton Dickinson and Company: Key Financials

Figure 47 Becton Dickinson and Company: Segmental Revenue

Figure 48 Becton Dickinson and Company: Geographical Revenue

Figure 49 Merck: Key Financials

Figure 50 Merck: Segmental Revenue

Figure 51 Merck: Geographical Revenue

Figure 52 Agilent Technologies: Key Financials

Figure 53 Agilent Technologies: Segmental Revenue

Figure 54 Agilent Technologies: Geographical Revenue

Figure 55 TCS Biosciences Ltd: Key Financials

Figure 56 TCS Biosciences Ltd: Segmental Revenue

Figure 57 TCS Biosciences Ltd: Geographical Revenue